drugset / Trial / NCT05948644
The Safety, Tolerability, and Pharmacokinetics of TPN171H Tablets in Patients With Pulmonary Arterial Hypertension
Phase 1
Completed
10 enrolled
Vigonvita Life Sciences
Shanghai Institute of Materia Medica, Chinese Academy of Sciences · collab
NaSingle-groupOpen-labelTreatment
Summary
Exploring the safety, tolerability, and pharmacokinetic (PK) characteristics of oral TPN171H tablets in patients with Pulmonary Arterial Hypertension under continuous multiple administration conditions, providing a basis for determining the administration plan and recommended dosage in phase II clinical study.
Timeline
- Start
- 2019-04-08
- Primary completion
- 2020-10-14
- Completion
- 2020-10-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TPN171H | Unknown | 10 mg | Oral |